Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3288604rdf:typepubmed:Citationlld:pubmed
pubmed-article:3288604lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:3288604lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:3288604lifeskim:mentionsumls-concept:C0004663lld:lifeskim
pubmed-article:3288604lifeskim:mentionsumls-concept:C0002645lld:lifeskim
pubmed-article:3288604lifeskim:mentionsumls-concept:C0055860lld:lifeskim
pubmed-article:3288604lifeskim:mentionsumls-concept:C0205430lld:lifeskim
pubmed-article:3288604lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:3288604pubmed:issue4lld:pubmed
pubmed-article:3288604pubmed:dateCreated1988-7-21lld:pubmed
pubmed-article:3288604pubmed:abstractTextThe efficacy of amoxycillin/clavulanic acid was compared with those of metronidazole, cefuroxime, metronidazole/ampicillin, metronidazole/gentamicin and metronidazole/cefuroxime, in experimental mixed infections produced in mice by subcutaneous inoculation of amoxycillin-resistant strains of Bacteroides fragilis and Escherichia coli. The combination of metronidazole/ampicillin failed to inhibit the growth of E. coli, and exerted only a transient effect on the numbers of Bact. fragilis in the groin abscesses. In contrast, amoxycillin/clavulanic acid prevented the development of the infection, eliminating both organisms. Metronidazole and cefuroxime, alone and in combination, were less effective than amoxycillin/clavulanic acid in inhibiting the growth of the infecting organisms. These results demonstrate the clinical potential of amoxycillin/clavulanic acid in prophylaxis, or in the therapy of mixed aerobe/anaerobe infections.lld:pubmed
pubmed-article:3288604pubmed:languageenglld:pubmed
pubmed-article:3288604pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288604pubmed:citationSubsetIMlld:pubmed
pubmed-article:3288604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3288604pubmed:statusMEDLINElld:pubmed
pubmed-article:3288604pubmed:monthAprlld:pubmed
pubmed-article:3288604pubmed:issn0305-7453lld:pubmed
pubmed-article:3288604pubmed:authorpubmed-author:SutherlandRRlld:pubmed
pubmed-article:3288604pubmed:authorpubmed-author:BealeA SASlld:pubmed
pubmed-article:3288604pubmed:authorpubmed-author:GisbyJJlld:pubmed
pubmed-article:3288604pubmed:issnTypePrintlld:pubmed
pubmed-article:3288604pubmed:volume21lld:pubmed
pubmed-article:3288604pubmed:ownerNLMlld:pubmed
pubmed-article:3288604pubmed:authorsCompleteYlld:pubmed
pubmed-article:3288604pubmed:pagination451-9lld:pubmed
pubmed-article:3288604pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:meshHeadingpubmed-meshheading:3288604-...lld:pubmed
pubmed-article:3288604pubmed:year1988lld:pubmed
pubmed-article:3288604pubmed:articleTitleEfficacy of amoxycillin/clavulanic acid in experimental Bacteroides fragilis/Escherichia coli mixed infections.lld:pubmed
pubmed-article:3288604pubmed:affiliationBeecham Pharmaceuticals Research Division, Betchworth, Surrey, UK.lld:pubmed
pubmed-article:3288604pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3288604pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3288604lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3288604lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3288604lld:pubmed